The new DNA test that was developed in the UK can predict whether patients at risk will have bowel cancer in the five years.
People with inflammatory inflammatory disease (IBD) – which includes cases such as ulcerative colitis and cunning – are four times more likely to obtain this type of cancer, also referred to as colon and rectum cancer.
As a preventive measure, the injured people usually get more offers in the form of a colonoscopy – but this new test is more than 90 % in predicting bowel cancer before it starts.
While colonoscopy can discover cancer cells in the intestine, the new research conducted by the UK Cancer Research Institute has managed to better predict any of these cancer cells that could turn into cancer.
They have developed more than 90 % of a minute in determining whether the patient will have colon and rectal cancer in the next five years.
The tests were conducted with tissue samples, but they hope that they are able to use their results to create a blood test that accomplishes the same and can be used as a diagnostic tool in hospitals.
“Most people who suffer from ulcerative colitis or Crohn's disease will not have bowel cancer,” Professor Trevor Graham from ICR said in a press statement.
But for those who have these conditions and show signs of Precancer in the colon, there are some difficult decisions that must be made.
“Either it was monitored regularly, hoping that it would not become cancer, or they removed the intestine to ensure that cancer is not infected in the future. None of these options is particularly enjoyable.
“Our test and the algorithm of people who suffer from IBD, the doctors who care about them, and the best possible information so that they can make the right decision on how to manage their cancer risks.”
Dr. Ian Volks, our CEO of ICR Research and Innovation, hopes that the test will provide people and money in unnecessary tests with attention to those who need it faster.
He said: “The treatment of bowel cancer is likely to be effective if you encounter the disease earlier,” he said.
“The presence of Crohn or colitis is a known risk of intestinal cancer, but the risk is very different between different people, and so far we have had to follow an approach that fits everything to prevent it.
“With this research, we can focus the resources on the treatment of people with IBD who are really at great risk, providing health services for valuable time and money. We can also give those who have peace of mind at a lower risk and remove fear of bowel cancer in the future.”
